Alingsas Lasarett

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease2 trials
• Stroke1 trial

Phase

• Phase 41 trial

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Amgen1 trial
• Sahlgrenska University Hospital1 trial

Running trials

• Active, not recruiting

  EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

  NCT05284747· Phase 4· Amgen· Source

• Recruiting

  The Physical Activity Post Myocardial Infarction SWEDEHEART Prospective Cohort Study

  NCT05339477· Sahlgrenska University Hospital· Source

  Contact: Petter Tollemark

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease1 recruiting